SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-020211
Filing Date
2022-10-26
Accepted
2022-10-26 17:14:25
Documents
12
Period of Report
2022-10-26
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K lyra-20221026.htm   iXBRL 8-K 56715
  Complete submission text file 0000950170-22-020211.txt   178836

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyra-20221026_lab.xml EX-101.LAB 14018
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyra-20221026.xsd EX-101.SCH 2481
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyra-20221026_pre.xml EX-101.PRE 10295
6 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20221026_htm.xml XML 4915
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 221334072
SIC: 3841 Surgical & Medical Instruments & Apparatus